592 related articles for article (PubMed ID: 27795350)
21. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.
Gilchuk P; Guthals A; Bonissone SR; Shaw JB; Ilinykh PA; Huang K; Bombardi RG; Liang J; Grinyo A; Davidson E; Chen EC; Gunn BM; Alter G; Saphire EO; Doranz BJ; Bukreyev A; Zeitlin L; Castellana N; Crowe JE
Front Immunol; 2021; 12():706757. PubMed ID: 34335620
[TBL] [Abstract][Full Text] [Related]
22. Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform.
Cnops L; Van den Eede P; Pettitt J; Heyndrickx L; De Smet B; Coppens S; Andries I; Pattery T; Van Hove L; Meersseman G; Van Den Herrewegen S; Vergauwe N; Thijs R; Jahrling PB; Nauwelaers D; Ariën KK
J Infect Dis; 2016 Oct; 214(suppl 3):S192-S202. PubMed ID: 27247341
[TBL] [Abstract][Full Text] [Related]
23. Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease.
Luczkowiak J; Lasala F; Mora-Rillo M; Arribas JR; Delgado R
J Infect Dis; 2018 Nov; 218(suppl_5):S574-S581. PubMed ID: 29939289
[TBL] [Abstract][Full Text] [Related]
24. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.
Brannan JM; Froude JW; Prugar LI; Bakken RR; Zak SE; Daye SP; Wilhelmsen CE; Dye JM
J Infect Dis; 2015 Oct; 212 Suppl 2():S282-94. PubMed ID: 25943199
[TBL] [Abstract][Full Text] [Related]
25. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H
Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918
[TBL] [Abstract][Full Text] [Related]
26. Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study.
Halfmann PJ; Eisfeld AJ; Watanabe T; Maemura T; Yamashita M; Fukuyama S; Armbrust T; Rozich I; N'jai A; Neumann G; Kawaoka Y; Sahr F
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007654. PubMed ID: 31369554
[TBL] [Abstract][Full Text] [Related]
27. Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
Cross RW; Boisen ML; Millett MM; Nelson DS; Oottamasathien D; Hartnett JN; Jones AB; Goba A; Momoh M; Fullah M; Bornholdt ZA; Fusco ML; Abelson DM; Oda S; Brown BL; Pham H; Rowland MM; Agans KN; Geisbert JB; Heinrich ML; Kulakosky PC; Shaffer JG; Schieffelin JS; Kargbo B; Gbetuwa M; Gevao SM; Wilson RB; Saphire EO; Pitts KR; Khan SH; Grant DS; Geisbert TW; Branco LM; Garry RF
J Infect Dis; 2016 Oct; 214(suppl 3):S210-S217. PubMed ID: 27587634
[TBL] [Abstract][Full Text] [Related]
28. Immune memory to Sudan virus: comparison between two separate disease outbreaks.
Sobarzo A; Eskira Y; Herbert AS; Kuehne AI; Stonier SW; Ochayon DE; Fedida-Metula S; Balinandi S; Kislev Y; Tali N; Lewis EC; Lutwama JJ; Dye JM; Yavelsky V; Lobel L
Viruses; 2015 Jan; 7(1):37-51. PubMed ID: 25569078
[TBL] [Abstract][Full Text] [Related]
29. Anti-Ebola MAb 17A3 reacts with bovine and human alpha-2-macroglobulin proteins.
Yu JS; Ma BJ; Scearce RM; Liao HX; Haynes BF
J Virol Methods; 2010 Sep; 168(1-2):248-50. PubMed ID: 20447422
[TBL] [Abstract][Full Text] [Related]
30. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.
Yu JS; Liao HX; Gerdon AE; Huffman B; Scearce RM; McAdams M; Alam SM; Popernack PM; Sullivan NJ; Wright D; Cliffel DE; Nabel GJ; Haynes BF
J Virol Methods; 2006 Nov; 137(2):219-28. PubMed ID: 16857271
[TBL] [Abstract][Full Text] [Related]
31. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus.
Macneil A; Reed Z; Rollin PE
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1175. PubMed ID: 21666792
[TBL] [Abstract][Full Text] [Related]
32. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.
Becquart P; Mahlakõiv T; Nkoghe D; Leroy EM
PLoS One; 2014; 9(6):e96360. PubMed ID: 24914933
[TBL] [Abstract][Full Text] [Related]
33. Serological evidence of Ebola virus infection in Indonesian orangutans.
Nidom CA; Nakayama E; Nidom RV; Alamudi MY; Daulay S; Dharmayanti IN; Dachlan YP; Amin M; Igarashi M; Miyamoto H; Yoshida R; Takada A
PLoS One; 2012; 7(7):e40740. PubMed ID: 22815803
[TBL] [Abstract][Full Text] [Related]
34. Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay.
Jansen van Vuren P; Grobbelaar A; Storm N; Conteh O; Konneh K; Kamara A; Sanne I; Paweska JT
J Clin Microbiol; 2016 Feb; 54(2):359-67. PubMed ID: 26637383
[TBL] [Abstract][Full Text] [Related]
35. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.
Richardson ET; Kelly JD; Barrie MB; Mesman AW; Karku S; Quiwa K; Marsh RH; Koedoyoma S; Daboh F; Barron KP; Grady M; Tucker E; Dierberg KL; Rutherford GW; Barry M; Jones JH; Murray MB; Farmer PE
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005087. PubMed ID: 27846221
[TBL] [Abstract][Full Text] [Related]
36. A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses.
Wu F; Zhang S; Zhang Y; Mo R; Yan F; Wang H; Wong G; Chi H; Wang T; Feng N; Gao Y; Xia X; Zhao Y; Yang S
Viruses; 2020 Jan; 12(1):. PubMed ID: 31947873
[TBL] [Abstract][Full Text] [Related]
37. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.
Sobarzo A; Stonier SW; Radinsky O; Gelkop S; Kuehne AI; Edri A; Herbert AS; Fedida-Metula S; Lutwama JJ; Yavelsky V; Davis C; Porgador A; Dye JM; Lobel L
EBioMedicine; 2019 Aug; 46():215-226. PubMed ID: 31326432
[TBL] [Abstract][Full Text] [Related]
38. Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
Anderson MS; Niemuth NA; Sabourin CL; Badorrek CS; Bounds CE; Rudge TL
PLoS One; 2020; 15(8):e0238196. PubMed ID: 32841291
[TBL] [Abstract][Full Text] [Related]
39. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
40. Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein.
Ikegami T; Niikura M; Saijo M; Miranda ME; Calaor AB; Hernandez M; Acosta LP; Manalo DL; Kurane I; Yoshikawa Y; Morikawa S
Clin Diagn Lab Immunol; 2003 Jul; 10(4):552-7. PubMed ID: 12853385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
